Table 2 The top 20 clusters and their representative enriched terms (one per cluster)
From: ENPP1 deletion causes mouse osteoporosis via the MKK3/p38 MAPK/PCNA signaling pathway
Description | Count | % | Log10(P) | Log10(q) |
|---|---|---|---|---|
MAPK signaling pathway | 20 | 86.96 | − 37.95 | − 33.89 |
Ras signaling pathway | 9 | 39.13 | − 12.52 | − 8.76 |
PID TNF PATHWAY | 6 | 26.09 | − 11.87 | − 8.29 |
Regulation of kinase activity | 11 | 47.83 | − 11.26 | − 7.74 |
VEGFA-VEGFR2 signaling pathway | 9 | 39.13 | − 10.47 | − 7.11 |
Osteoclast differentiation | 6 | 26.09 | − 9.09 | − 6.05 |
Positive regulation of cell migration | 8 | 34.78 | − 8.08 | − 5.17 |
Focal adhesion | 6 | 26.09 | − 7.98 | − 5.12 |
ST P38 MAPK PATHWAY | 4 | 17.39 | − 7.66 | − 4.9 |
Signaling by receptor tyrosine kinases | 7 | 30.43 | − 6.87 | − 4.21 |
VEGF signaling pathway | 4 | 17.39 | − 6.83 | − 4.19 |
Platelet activation, signaling, and aggregation | 5 | 21.74 | − 5.7 | − 3.23 |
Actin filament-based process | 7 | 30.43 | − 5.63 | − 3.18 |
Cell junction organization | 6 | 26.09 | − 4.81 | − 2.5 |
Apoptosis modulation and signaling | 3 | 13.04 | − 4.23 | − 2.08 |
Hippo signaling regulation pathways | 3 | 13.04 | − 4.15 | − 2.02 |
Muscle structure development | 5 | 21.74 | − 3.86 | − 1.79 |
Negative regulation of secretion by cell | 3 | 13.04 | − 3.64 | − 1.61 |
Oxytocin signaling pathway | 3 | 13.04 | − 3.6 | − 1.57 |
Regulation of cell activation | 4 | 17.39 | − 2.76 | − 0.86 |